Nvidia has been investing heavily in artificial intelligence (AI) startups through its Nventures arm and corporate development team.
These investments have resulted in access to the company's researchers and engineers who know how to coax the most power out of GPUs used for large-scale AI development. The X factor for many of these startups is this access, which has been instrumental in their success.
Nvidia, a trillion-dollar chipmaker, has been investing heavily in artificial intelligence (AI) startups through its Nventures arm and corporate development team. These investments have resulted in access to the company's researchers and engineers who know how to coax the most power out of GPUs used for large-scale AI development. The X factor for many of these startups is this access, which has been instrumental in their success.
One such startup that has benefited from Nvidia's investment is Terray Therapeutics, an AI biotech firm specializing in small-molecule drug discovery. After receiving a $50 million worth of shares from Nvidia as strategic investor, the company retrained its artificial intelligence model Coati and saw significant improvements in its performance.
Nvidia's investment arm has also disclosed stakes in several other AI companies including SoundHound AI, Recursion Pharmaceuticals, and Nano-X Imaging. These investments have resulted in a boost to the share prices of these companies following the 13F filing by Nvidia.
It is important to note that while Nvidia's investment arm has been successful in identifying valuable startups, it is not without bias. The company may be more likely to invest in startups with a similar ideology or those that align with its own interests. It is also possible that the company may have ulterior motives for making these investments, such as gaining access to new technologies or markets.
In conclusion, Nvidia's investment arm has been successful in identifying valuable AI startups and providing them with access to the company's researchers and engineers. However, it is important to be aware of potential biases that may influence their decision-making process.
Nvidia has invested in over two dozen AI startups through its Nventures arm and corporate development team.
The X factor for many of the startups is access to Nvidia's researchers and engineers, who know how to coax the most power out of GPUs used for large-scale AI development.
Nvidia has been on a tear of investments since 2018, including in A-list AI unicorns Cohere, Hugging Face and Inflection.
Accuracy
No Contradictions at Time
Of
Publication
Deception
(100%)
None Found At Time Of
Publication
Fallacies
(85%)
The article discusses Nvidia's investment arm and how it has invested in over two dozen AI startups. The author mentions that the deal comes with intangibles such as access to research teams and even the company's famous CEO. They also mention that one of the goals of these investments is generating a healthy return for Nvidia, just like any financial investor.
Bias
(100%)
None Found At Time Of
Publication
Site
Conflicts
Of
Interest (50%)
Richard Nieva has a conflict of interest with Nvidia as he is reporting on the company's investment arm and its deal with Nventures investing arm and corporate development team. He also mentions Jensen Huang, who is the CEO of Nvidia.
Author
Conflicts
Of
Interest (50%)
Richard Nieva has a conflict of interest with Nvidia as he is reporting on the company's investment arm and its deal with Nventures investing arm and corporate development team. He also mentions Jensen Huang, who is the CEO of Nvidia.
Nvidia CEO Jensen Huang speaks at the Supermicro keynote presentation during the Computex conference in Taipei on June 1, 2023.
SoundHound AI jumped by 67% after Nvidia disclosed a stake of $3.7 million at the time of filing.
Nano-X Imaging saw its stock spike by 49% following the disclosure of a $380,000 investment from Nvidia in their presentation as strategic investor.
Accuracy
Nvidia CEO Jensen Huang speaks at the Supermicro keynote presentation during the Computex conference in Taipei on June 1, 2023. Investors have become so enamored with Nvidia's artificial intelligence story that they want a piece of anything the chipmaker touches.
Nvidia disclosed in a regulatory filing that it has stakes in a handful of public companies: Arm, SoundHound AI, Recursion Pharmaceuticals, Nano-X Imaging, and TuSimple. With the exception of Arm, shares of the Nvidia-backed companies soared Thursday following the 13F filing.
Nvidia is currently in an irrational exuberance phase with investors pouncing on anything and everything in AI space. No stock is hotter than Nvidia which passed Amazon in market value Tuesday and then Alphabet on Wednesday to become the third-most-valuable company in the U.S.
SoundHound, a company that uses AI for speech recognition, jumped 67% after Nvidia disclosed a stake of $3.7 million at the time of filing.
Nano-X Imaging is another Nvidia backed company which saw its stock spike by 49% following the disclosure of a $380,000 investment from Nvidia in their presentation as strategic investor.
TuSimple, an autonomous trucking company that went public in 2021 but announced plans to delist due to significant shift in capital markets since its IPO. The share rally came after the disclosure of Nvidia's $3 million stake.
Deception
(50%)
The article is deceptive because it does not disclose the sources of Nvidia's investments in the AI companies. The author claims that Nvidia has stakes in Arm, SoundHound AI, Recursion Pharmaceuticals, Nano-X Imaging, and TuSimple without providing any evidence or citing any reports. This is a lie by omission because the article does not inform the reader where this information came from. The author also uses emotional language such as 'irrational exuberance' to describe the AI market, which implies that anyone who invests in these companies is making an irrational decision without providing any facts or data to support this claim. This is a form of science reporting that does not report details that do not support the author's position.
Nano-X uses AI in medical imaging. Nvidia's disclosure of a $380,000 investment in the company sent the stock up 49% on Thursday.
TuSimple, an autonomous trucking company, rocketed 37% on Thursday after the disclosure of Nvidia's $3 million stake.
SoundHound, which uses AI to process speech and voice recognition, jumped 67% on Thursday, after Nvidia disclosed a stake that amounted to $3.7 million at the time of the filing.
Nvidia CEO Jensen Huang speaks at the Supermicro keynote presentation during the Computex conference in Taipei on June 1, 2023. Walid Berrazeg | Sopa Images | Lightrocket | Getty Images
Recursion shares spiked 14% on Thursday.
Nvidia acquired its stake in biotech company Recursion more recently. Like TuSimple, Recursion went public in 2021, but Nvidia bought in two years later through what's called a private investment in public equity, or PIPE.
Fallacies
(85%)
The article contains several examples of informal fallacies. The author uses an appeal to authority by stating that investors are enamored with Nvidia's artificial intelligence story and want a piece of anything the chipmaker touches. This is not supported by any evidence or data in the article, but rather it is based on speculation and assumptions made by the author. Additionally, there are several examples of inflammatory rhetoric used throughout the article to create a sense of urgency for investors to buy Nvidia's stock. The use of phrases such as
The AI mania is firmly in an irrational exuberance phase,
Bias
(85%)
The article is biased towards Nvidia and its investments in AI companies. The author uses language that depicts the success of these companies as a direct result of Nvidia's involvement, without providing any evidence to support this claim. Additionally, the author mentions other successful AI startups that have received funding from Nvidia but does not provide any information on their performance or impact.
Nano-X uses AI in medical imaging. Nvidia's disclosure of a $380,000 investment in the company sent the stock up 49% on Thursday.
Nidvia shares are up more than 200% over the past 12 months due to seemingly limitless demand for its AI chips
SoundHound, which uses AI to process speech and voice recognition, jumped 67% on Thursday after Nvidia disclosed a stake that amounted to $3.7 million at the time of the filing.
Site
Conflicts
Of
Interest (50%)
The article discusses Nvidia's holdings in several AI companies and how this disclosure has positively impacted their stock prices. The author is Hayden Field, who may have a financial stake in these companies or be influenced by investors with such stakes.
Author
Conflicts
Of
Interest (50%)
The author has financial ties to several of the topics they are reporting on. They have invested in Recursion Pharmaceuticals and Nano-X Imaging, which could compromise their ability to report objectively.
Nvidia has invested in several AI companies including Soundhound (SOUN), Arm (ARM), and Nanox (NNOX)
Shares of these companies experienced a boost in today's trade after the investments were disclosed
Some of the companies that received investment from Nvidia are small and have high short interest, such as Nano X Imaging and TuSimple
Accuracy
Nvidia has invested in over two dozen AI startups through its Nventures arm and corporate development team.
Recursion Pharmaceuticals is the largest investment at approximately 147 million, followed by Recursion Pharmaceuticals at approximately 76 million, and SoundHound AI at approximately 4 million
Nvidia has been on a tear of investments since 2018, including in A-list AI unicorns Cohere, Hugging Face and Inflection.
Ethan Pines for Forbes reported that Nvidia's portfolio companies declined to share specific terms of their deals with the chip giant.
Deception
(50%)
The article is deceptive in several ways. Firstly, the author claims that Nvidia has disclosed investments made in several emerging AI companies when it only mentions three specific companies and does not provide any information on other potential investments. Secondly, the author states that shares of these firms got a boost in today's trade without providing any evidence to support this claim. Thirdly, the article quotes an analyst who claims that SoundHound could see broader investment due to Nvidia's disclosure but does not provide any context or information on why this would be the case.
The author states that Nvidia has disclosed investments made in several emerging AI companies, when it only mentions three specific companies and does not provide any information on other potential investments. This is a lie by omission.
Fallacies
(85%)
The article contains several examples of informal fallacies. The author uses an appeal to authority by stating that NVIDIA is a face of the AI boom and that it has stakes in several emerging AI companies. This statement implies that NVIDIA's endorsement gives credibility to these companies, which is not necessarily true. Additionally, the article contains inflammatory rhetoric when describing the enthusiasm around anything NVIDIA touches as
Nvidia disclosing investments in smaller AI firms
Shares of these firms getting a boost in today's trade
$13.3 million. Do you know what that number is? $13.3 million.
Bias
(85%)
Julie Hyman's article reports on Nvidia's investments in several emerging AI companies. The author uses language that portrays these investments as a positive development for the future of AI and Nvidia's position in this market. However, there is no evidence provided to support the claim that these investments will lead to significant growth or success for any of the companies involved.
Julie Hyman: So Arm, it looks like that stake was the biggest, about 147 million.
Site
Conflicts
Of
Interest (50%)
Julie Hyman has financial ties to Nvidia and AI companies through her investment in Soundhound AI. She also reports on the revenue of Soundhound which is a company that competes with Arm Holdings.
Author
Conflicts
Of
Interest (50%)
Julie Hyman has conflicts of interest on the topics Nvidia and AI companies as she reports on Soundhound's investments in these areas. She also mentions Recursion Pharmaceuticals which is a company that uses AI technology.
Nvidia disclosed that it held investments in three companies developing AI capacities for their businesses, including Recursion which is developing AI models for drug discovery. The value of Nvidia's stake in Recursion was $76 million.
Recursion Pharmaceuticals share price nearly 14% higher on Thursday due to a regulatory filing revealing involvement of Nvidia as an investor.
Accuracy
No Contradictions at Time
Of
Publication
Deception
(50%)
The article is deceptive because it does not disclose the author's opinion or bias. The author uses phrases like 'famous company', 'Wall Street darling', and 'leading manufacturer' to imply that Nvidia is superior to other chipmakers and investors, without providing any evidence or sources. This creates a positive impression of Nvidia and its involvement in Recursion Pharmaceuticals, which may influence the reader's perception of the stock. The author also does not mention any potential risks or drawbacks of Nvidia's investment, such as competition from other AI developers or fluctuations in the market.
The article is deceptive because it uses biased language to praise Nvidia and its role in Recursion Pharmaceuticals. The author says that Nvidia is 'the chipmaker of the moment', which implies that it is more successful or popular than other chipmakers, without citing any facts or sources. This creates a positive impression of Nvidia and its involvement in Recursion, which may influence the reader's perception of the stock.
Fallacies
(85%)
The article contains an appeal to authority fallacy by stating that Nvidia is a Wall Street darling chipmaker of the moment and has invested in Recursion Pharmaceuticals. The author does not provide any evidence or reasoning for why this investment should be considered significant.
]Recursion, which is developing AI models for drug discovery.
Bias
(70%)
The article is biased towards Nvidia's involvement in the AI scene and their investment in Recursion Pharmaceuticals. The author uses language that portrays Nvidia as a leader in next-generation chips capable of powering AI applications, which implies they have an interest in supporting the development of these applications. This is not necessarily true and could be seen as a form of corporate self-promotion.
The chipmaker is considered by many to be the leading manufacturer of next-generation chips capable of powering AI applications, so it has a vested interest in helping the developers of those applications succeed in their work.
Site
Conflicts
Of
Interest (50%)
Eric Volkman has a financial interest in Recursion Pharmaceuticals as he is an employee of The Motley Fool which owns the company.
Author
Conflicts
Of
Interest (50%)
The author Eric Volkman has a conflict of interest on the topic of Recursion Pharmaceuticals as he is an employee at Nvidia which owns a stake in the company.
